Form 8-K - Current report:
SEC Accession No. 0001570562-20-000114
Filing Date
2020-10-22
Accepted
2020-10-22 16:28:29
Documents
14
Period of Report
2020-10-22
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K eols-20201022.htm   iXBRL 8-K 36076
  Complete submission text file 0001570562-20-000114.txt   180967

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20201022.xsd EX-101.SCH 2430
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20201022_cal.xml EX-101.CAL 718
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20201022_def.xml EX-101.DEF 1655
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20201022_lab.xml EX-101.LAB 24975
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20201022_pre.xml EX-101.PRE 13195
7 EXTRACTED XBRL INSTANCE DOCUMENT eols-20201022_htm.xml XML 11047
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 201255168
SIC: 2834 Pharmaceutical Preparations